Evidence map›Paper›PMID 37891710›Full record

SynthesisActa obstetricia et gynecologica Scandinavica2024

Treatments for hyperemesis gravidarum: A systematic review.

Marie-Therese Vinnars, Maria Forslund, Ing-Marie Claesson, Annicka Hedman, Nathalie Peira, Hanna Olofsson, Emma Wernersson, Hanna Ulfsdottir

Open access · diamondAbstract readSystematic Review
In one paragraph

Synthesis in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Treatments for hyperemesis gravidarum: A systematic review.Acta obstetricia et gynecologica Scandinavica · 2024
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Marie-Therese VinnarsDepartment of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.
Maria ForslundDepartment of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Akademin, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-6674-3849
Ing-Marie ClaessonDepartment of Obstetrics and Gynecology, and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Annicka HedmanSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden.
Nathalie PeiraSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden.
Hanna OlofssonSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden.
Emma WernerssonSwedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden.
Hanna UlfsdottirDivision of Reproductive Health, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9718-754X
SBU - Swedish Agency for Health Technology Assessment and Assessment of Social Services · SEKarolinska Institutet · SELinköping University · SESahlgrenska University Hospital · SEUmeå University · SE

Funding

Statens beredning för medicinsk och social utvärdering
6 · The paper itself

Abstract

introductionHyperemesis gravidarum affects 0.3%-3% of pregnant women each year and is the leading cause of hospitalization in early pregnancy. Previous systematic reviews of available treatments have found a lack of consistent evidence, and few studies of high quality. Since 2016, no systematic review has been conducted and an up-to date review is requested. In a recent James Lind Alliance collaboration, it was clear that research on effective treatments is a high priority for both patients and clinicians. MATERIAL AND

methodsSearches without time limits were performed in the AMED, CINAHL, Cochrane Library, EMBASE, Medline, PsycINFO, and Scopus databases until June 26, 2023. Studies published before October 1, 2014 were identified from the review by O'Donnell et al., 2016. Selection criteria were randomized clinical trials and non-randomized studies of interventions comparing treatment of hyperemesis gravidarum with another treatment or placebo. Outcome variables included were: degree of nausea; vomiting; inability to tolerate oral fluids or food; hospital treatment; health-related quality of life, small-for-gestational-age infant; and preterm birth. Abstracts and full texts were screened, and risk of bias of the studies was assessed independently by two authors. Synthesis without meta-analysis was performed, and certainty of evidence was assessed using the GRADE approach. PROSPERO (CRD42022303150).

resultsTwenty treatments were included in 25 studies with low or moderate risk of bias. The certainty of evidence was very low for all treatments except for acupressure in addition to standard care, which showed a possible moderate decrease in nausea and vomiting, with low certainty of evidence.

conclusionsSeveral scientific knowledge gaps were identified. Studies on treatments for hyperemesis gravidarum are few, and the certainty of evidence for different treatments is either low or very low. To establish more robust evidence, it is essential to use validated scoring systems, the recently established diagnostic criteria, clear descriptions and measurements of core outcomes and to perform larger studies.

Indexed as

Hyperemesis GravidarumPremature BirthFemaleHumansInfant, NewbornNauseaPregnancyPregnant PeopleQuality of Lifehyperemesis gravidaruminterventionnauseaPUQEquality of lifesystematic reviewtreatmentvomiting

Identifiers

PMID37891710
PMCPMC10755124
OpenAlexW4387996395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.